XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -10.05%432.47M | -8.51%108.04M | -9.61%102.53M | -10.15%121.83M | -11.96%100.08M | -10.60%480.78M | -13.74%118.09M | -11.16%113.43M | -8.54%135.59M | -9.04%113.67M |
Operating revenue | -10.05%432.47M | -8.51%108.04M | -9.61%102.53M | -10.15%121.83M | -11.96%100.08M | -10.60%480.78M | -13.74%118.09M | -11.16%113.43M | -8.54%135.59M | -9.04%113.67M |
Cost of revenue | -10.73%182.53M | -15.39%44.51M | -12.10%42.17M | -6.32%51.16M | -9.34%44.69M | -8.62%204.48M | -7.42%52.6M | -8.99%47.98M | -10.46%54.61M | -7.43%49.29M |
Gross profit | -9.54%249.94M | -2.98%63.54M | -7.79%60.35M | -12.74%70.66M | -13.97%55.39M | -12.01%276.3M | -18.22%65.49M | -12.69%65.45M | -7.20%80.98M | -10.24%64.38M |
Operating expense | -8.04%235.65M | -8.87%59.96M | -3.32%58.37M | -4.65%59.27M | -14.54%58.06M | -5.80%256.26M | -10.87%65.8M | -9.08%60.38M | -6.61%62.16M | 4.11%67.93M |
Selling and administrative expenses | -7.38%218.44M | -7.95%56.26M | -1.93%54.01M | -3.88%54.69M | -14.78%53.48M | -5.51%235.85M | -10.71%61.12M | -9.24%55.08M | -6.57%56.9M | 5.36%62.76M |
-Selling and marketing expense | -4.62%159.62M | -5.87%41.67M | -4.24%38.27M | -3.19%40.25M | -5.08%39.42M | -8.02%167.35M | -9.08%44.27M | -9.64%39.97M | -7.54%41.58M | -5.70%41.53M |
-General and administrative expense | -14.13%58.82M | -13.43%14.58M | 4.17%15.74M | -5.73%14.44M | -33.77%14.06M | 1.24%68.5M | -14.73%16.85M | -8.15%15.11M | -3.83%15.32M | 36.74%21.23M |
Depreciation amortization depletion | -15.68%17.21M | -20.89%3.7M | -17.76%4.36M | -13.01%4.58M | -11.53%4.57M | -9.01%20.41M | -12.92%4.68M | -7.39%5.3M | -6.97%5.26M | -8.99%5.17M |
-Depreciation and amortization | -15.68%17.21M | -20.89%3.7M | -17.76%4.36M | -13.01%4.58M | -11.53%4.57M | -9.01%20.41M | -12.92%4.68M | -7.39%5.3M | -6.97%5.26M | -8.99%5.17M |
Operating profit | -28.70%14.29M | 1,269.61%3.58M | -60.97%1.98M | -39.45%11.4M | 24.87%-2.67M | -52.28%20.04M | -104.89%-306K | -40.69%5.08M | -9.10%18.82M | -154.88%-3.55M |
Net non-operating interest income expense | 1.60%-3.01M | 7.49%-716K | -0.92%-770K | -4.52%-763K | 3.91%-762K | -24.34%-3.06M | -6.17%-774K | -30.65%-763K | -36.45%-730K | -29.36%-793K |
Non-operating interest expense | -1.60%3.01M | -7.49%716K | 0.92%770K | 4.52%763K | -3.91%762K | 24.34%3.06M | 6.17%774K | 30.65%763K | 36.45%730K | 29.36%793K |
Other net income (expense) | 19.20%-8.64M | -947.57%-1.94M | -516.21%-2.29M | 109.31%933K | -414.92%-5.35M | -21.46%-10.69M | 98.04%-185K | 58.67%549K | -9,826.21%-10.02M | -714.79%-1.04M |
Gain on sale of security | 291.35%814K | --814K | ---- | ---- | ---- | -32.69%208K | ---- | ---- | ---- | ---- |
Special income (charges) | -2.08%-13.55M | -264.84%-4.13M | -14,173.68%-2.71M | 99.22%-82K | -316.87%-6.62M | -42.17%-13.27M | 87.87%-1.13M | ---19K | ---10.53M | ---1.59M |
-Less:Restructuring and merger&acquisition | -11.29%11.77M | 264.84%4.13M | 4,831.58%937K | -99.22%82K | 316.87%6.62M | 42.17%13.27M | -87.87%1.13M | --19K | --10.53M | --1.59M |
-Gain on sale of business | ---1.78M | --0 | ---1.78M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non- operating income (expenses) | 72.67%4.09M | 86.47%1.38M | -24.82%427K | 97.47%1.02M | 131.64%1.27M | 968.02%2.37M | 2,363.33%739K | 64.16%568K | 399.03%514K | 314.01%550K |
Income before tax | -58.04%2.64M | 173.12%925K | -122.09%-1.07M | 43.29%11.57M | -63.11%-8.78M | -79.54%6.29M | 67.51%-1.27M | -41.57%4.86M | -60.18%8.07M | -189.31%-5.38M |
Income tax | 159.17%8.38M | 181.89%493K | 98.74%4.72M | 90.53%5.27M | -61.09%-2.11M | -63.73%3.24M | 73.40%-602K | -18.18%2.38M | -56.73%2.77M | -169.61%-1.31M |
Net income | -288.43%-5.75M | 165.16%432K | -333.41%-5.8M | 18.63%6.29M | -63.75%-6.67M | -86.01%3.05M | 59.33%-663K | -54.12%2.48M | -61.77%5.3M | -198.24%-4.08M |
Net income continuous Operations | -288.43%-5.75M | 165.16%432K | -333.41%-5.8M | 18.63%6.29M | -63.75%-6.67M | -86.01%3.05M | 59.33%-663K | -54.12%2.48M | -61.77%5.3M | -198.24%-4.08M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -288.43%-5.75M | 165.16%432K | -333.41%-5.8M | 18.63%6.29M | -63.75%-6.67M | -86.01%3.05M | 59.33%-663K | -54.12%2.48M | -61.77%5.3M | -198.24%-4.08M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -288.43%-5.75M | 165.16%432K | -333.41%-5.8M | 18.63%6.29M | -63.75%-6.67M | -86.01%3.05M | 59.33%-663K | -54.12%2.48M | -61.77%5.3M | -198.24%-4.08M |
Basic earnings per share | -287.50%-0.3 | 166.67%0.02 | -330.77%-0.3 | 17.86%0.33 | -66.67%-0.35 | -86.09%0.16 | 66.67%-0.03 | -55.17%0.13 | -62.16%0.28 | -195.45%-0.21 |
Diluted earnings per share | -287.50%-0.3 | 166.67%0.02 | -330.77%-0.3 | 17.86%0.33 | -66.67%-0.35 | -85.96%0.16 | 66.67%-0.03 | -53.57%0.13 | -61.11%0.28 | -195.45%-0.21 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |